Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (121-130 of 269) with videos related to

Pageof 27
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 20, 2003
Beneficial effects of antioxidant vitamins on the stenotic kidneyAlejandro R Chade, Martin Rodriguez-Porcel, Joerg Herrmann, et al.
Frontiers in Cardiovascular Medicine|August 23, 2021
TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-RegressionKonstantinos Marmagkiolis, Dominique J Monlezun, Mehmet Cilingiroglu, et al.
American Journal of Hematology|November 5, 2016
Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patientsJohn C Reneau, Dennis Asante, Holly van Houten, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive CausesDinu V Balanescu, Richard Bloomingdale, Teodora Donisan, et al.
Cell Metabolism|September 6, 2018
Glycolytic Stimulation Is Not a Requirement for M2 Macrophage DifferentiationFeilong Wang, Song Zhang, Ivan Vuckovic, et al.
Cardiovascular Research|April 2, 2003
Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculatureMartin Rodriguez-Porcel, Amir Lerman, Joerg Herrmann, et al.
Pacing and Clinical Electrophysiology : PACE|February 16, 2021
Outcomes of cardiac resynchronization therapy in patients with chemotherapy-induced cardiomyopathyFatima M Ezzeddine, Antoine N Saliba, Vaibhav Jain, et al.
American Journal of Hematology|November 19, 2016
Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitorsHayan Jouni, Mary C Aubry, Martha Q Lacy, et al.
Circulation|October 23, 2002
Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarctionJoerg Herrmann, Amir Lerman, Dietrich Baumgart, et al.
Circulation Research|September 8, 2007
Chronic proteasome inhibition contributes to coronary atherosclerosisJoerg Herrmann, Ardan M Saguner, Daniele Versari, et al.
Pageof 27

Showing results (121-130 of 269) with videos related to

Sort By:
Pageof 27
Hypertension (Dallas, Tex. : 1979)|August 20, 2003
Beneficial effects of antioxidant vitamins on the stenotic kidneyAlejandro R Chade, Martin Rodriguez-Porcel, Joerg Herrmann, et al.
Frontiers in Cardiovascular Medicine|August 23, 2021
TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-RegressionKonstantinos Marmagkiolis, Dominique J Monlezun, Mehmet Cilingiroglu, et al.
American Journal of Hematology|November 5, 2016
Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patientsJohn C Reneau, Dennis Asante, Holly van Houten, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive CausesDinu V Balanescu, Richard Bloomingdale, Teodora Donisan, et al.
Cell Metabolism|September 6, 2018
Glycolytic Stimulation Is Not a Requirement for M2 Macrophage DifferentiationFeilong Wang, Song Zhang, Ivan Vuckovic, et al.
Cardiovascular Research|April 2, 2003
Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculatureMartin Rodriguez-Porcel, Amir Lerman, Joerg Herrmann, et al.
Pacing and Clinical Electrophysiology : PACE|February 16, 2021
Outcomes of cardiac resynchronization therapy in patients with chemotherapy-induced cardiomyopathyFatima M Ezzeddine, Antoine N Saliba, Vaibhav Jain, et al.
American Journal of Hematology|November 19, 2016
Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitorsHayan Jouni, Mary C Aubry, Martha Q Lacy, et al.
Circulation|October 23, 2002
Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarctionJoerg Herrmann, Amir Lerman, Dietrich Baumgart, et al.
Circulation Research|September 8, 2007
Chronic proteasome inhibition contributes to coronary atherosclerosisJoerg Herrmann, Ardan M Saguner, Daniele Versari, et al.
Pageof 27